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In the context of globally escalating antimicrobial resistance (AMR), optimising 
antimicrobial use internationally is critical. Surgical antibiotic prophylaxis (SAP) is a 
high-volume area of prescribing with significant rates of inappropriate prolonged 
prescription and compliance issues with timing, choice and dose. [1-8]. Inappropriate 
SAP represents a short-term risk to patients, via unnecessary use, and mid to long-
term risks in terms of contributing to antimicrobial resistance, and is therefore logical 
to target for optimisation of prescribing within hospitals.  
 
What is currently being done to address SAP internationally? Successful interventions 
to improve SAP prescribing include studies in both resource limited and resource rich 
settings, and include the collaborative development of guidelines, data collection on 
compliance with guidelines and quality assurance cycles with audit and direct 
prescriber feedback [7, 9-11]. However, in both contexts suboptimal SAP prescribing 
persists, and barriers to implementation are evident, including the enduring belief 
within surgery regarding the benefit of post-operative SAP administration to prevent 
SSI [10, 12, 13]. This raises an important question: in contexts where there are 
established guidelines and surveillance mechanisms in place, what factors contribute 
to the continued persistence of suboptimal prescribing, and what can we do to address 
them?  
 
One consistently under-emphasised aspect – with emerging evidence reinforcing its 
critical importance [14] – is the influence of social factors in antimicrobial decision-
making. For example, the existence of guideline discordant prescribing “etiquette” has 
consistently been observed within hospitals and evidence is clear regarding the 
significant role of hierarchy (and consequent fear of disapproval) and fear of adverse 
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patient outcomes in promoting inappropriate antimicrobial prescribing [15-17].  In the 
operating theatre, social influences such as hierarchical relations and inter-profession 
interactions have been demonstrated to influence decision-making and 
communication, and emerging evidence illustrates that this is also the case for SAP 
decision-making [18-21].  It has been suggested that surgery as a specialty, 
particularly in the operating theatre environment, may adhere more strongly than 
other specialties to hierarchical structures; this holds despite wider organisational 
movements to change these kinds of power dynamics [22]. Persistence of hierarchical 
structures, for example strict adherence to senior consultant decision-making with 
little questioning from junior doctors or nursing staff, results in consequences such as 
communication barriers which are identified as an issue in operating theatres as a 
direct result of team hierarchies[23]. How this relates to SAP is not well understood.   
 
Antibiotic decision-making within operating theatres has received only very limited 
attention. Surgical antibiotic prophylaxis, while seemingly a simple, predominantly 
evidence-based intervention for which clinical interpretation should be limited (due to 
the absence of actual infection), is an area of immense and curious clinical variation. 
A mixed methods study identified both individual and organisational determinants of 
agreement with and adherence to surgical antibiotic prophylaxis guidelines [24]. 
These included clinicians wanting to act according to a sense of “what is right” and 
consistent with the hospital’s “school of thought”, perceived expectations from 
patients’ families and pharmaceutical company pressure, among other factors. In 
qualitative research by the authors on SAP decision-making, significant social 
influences were identified [21]. Relationship dynamics were shown to heavily 
influence antimicrobial decision-making, with the more senior members of the 
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medical team holding authority, and surgeons holding much greater influence than 
anaesthetists as a result of the perception that they hold the operative risk. The role of 
hierarchy within surgical teams in antibiotic decision-making more broadly is in turn 
supported by recent qualitative work documenting the presence of “shifting 
hierarchy” in which the most influential person on the team altered according to who 
was present on the ward round [25]. This is consistent with the authors’ SAP study, in 
which the seniority status of the anaesthetist vs the surgeon (i.e. consultant vs training 
registrar) was perceived to alter the decision-making dynamics around SAP.  
 
Physical presence in the operating theatre is perceived by surgeons to limit the 
antimicrobial stewardship (AMS) influence on SAP decision making. This is 
consistent with previous work identifying social distance from the treating team (i.e. 
the AMS team is not at the bedside) as a barrier to uptake of antimicrobial advice [21, 
26]. Prolonged SAP administration is perceived by clinicians as justified by a position 
of benevolence towards the individual patient [15, 27, 28]. In SAP decision-making 
there is no pre-existing infection, so benevolence is directed towards the risk of post-
operative infection. Importantly, as identified in further unpublished data by the 
authors (under review), interacting with a sense of benevolence toward the patient is 
also the sense of personal risk to the surgeon. Guidelines were not necessarily 
perceived to be protective against litigation, and local cultures of SAP administration 
(i.e. what everyone else does) were perceived as sometimes valued over clinical 
guidelines.  
 
(Non-concordant) ‘innovation’ around SAP has been shown to be widespread and 
certainly non-evidence based. It includes such techniques as “gentamicin fairy dust” 
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and other techniques of washing wounds with antibiotic solutions [29, 30]. The ethical 
issue of innovation in surgery more broadly has been explored in the literature, with 
tension between the need to innovate to improve patient safety and care and the 
development of innovative techniques without rigorous testing, which become 
normalised without true evidence of patient safety or benefit [31]. In addition, a 
reluctance of surgeons to apply regulatory standards to patients was described, and a 
tendency to apply innovation without rigorous research methodology to assess 
efficacy. This certainly appears to be the case with innovative SAP techniques, and 
the assumption of safety or “surgical comfort” within presumption of lack of risk 
towards the patient is described.  
 
Emerging data support the powerful role of social factors in influencing antimicrobial 
decision-making. SAP is a critical area to optimise, and the consideration of factors 
such as social structures and relationships, and design of interventions that address 
these issues (in addition to audit and feedback) may have exponentially greater power 
to influence and optimise prescribing in this area. The emotive issues such as 
operative risk (and ownership of this risk), social hierarchical influences, and mistrust 
in guidelines must be addressed in order to bring about change in this area.  
Recommendations:  
 
• AMS teams in hospitals need to move beyond regulation or surveillance of 
prescribing, toward a focus on the social and behavioural drivers of SAP.  
 
• New AMS strategies for SAP should incorporate social models of behaviour.  
Acknowledgements 
The support of the Australasian Society for Infectious Diseases is acknowledged. 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
6 
 
Funding 
This work was supported by an Advance Queensland Senior Research Fellowship and 
an Australian Research Council Linkage grant (LP140100020).   
Conflict of Interest 
The authors declare no conflict of interest.  
References  
1. Gharbi M, Doerholt K, Vergnano S, Bielicki JA, Paulus S, Menson E, et al. 
Using a simple point-prevalence survey to define appropriate antibiotic prescribing in 
hospitalised children across the UK. BMJ Open. 2016;6(11):e012675. 
2. National Centre for Antimicrobial Stewardship and Australian Commission on 
Safety and Quality in Health Care. Antimicrobial prescribing practice in Australian 
hospitals: Results of the 2015 Hospital National Antimicrobial Prescribing Survey. 
Sydney: ACSQHC, 2016. 
3. Point prevalence survey of healthcare-associated infections and antimicrobial 
use in European hospitals 2011–2012. Stockholm European Centre for Disease 
Prevention and Control, 2013. 
4. Muller A, Leroy J, Henon T, Patry I, Samain E, Chirouze C, et al. Surgical 
antibiotic prophylaxis compliance in a university hospital. Anaesth Crit Care Pain 
Med. 2015;34(5):289-94. 
5. Mousavi S, Zamani E, Bahrami F. An Audit of Perioperative Antimicrobial 
Prophylaxis: Compliance with the International Guidelines. J Res Pharm Pract. 
2017;6(2):126-9. 
6. Musmar SM, Ba'ba H, Owais A. Adherence to guidelines of antibiotic 
prophylactic use in surgery: a prospective cohort study in North West Bank, Palestine. 
BMC Surg. 2014;14:69. 
7. Brink AJ, Messina AP, Feldman C, Richards GA, van den Bergh D, Netcare 
Antimicrobial Stewardship Study A. From guidelines to practice: a pharmacist-driven 
prospective audit and feedback improvement model for peri-operative antibiotic 
prophylaxis in 34 South African hospitals. J Antimicrob Chemother. 2016. 
8. Schmitt C, Lacerda RA, Turrini RNT, Padoveze MC. Improving compliance 
with surgical antibiotic prophylaxis guidelines: A multicenter evaluation. Am J Infect 
Control. 2017. 
9. Aiken AM, Wanyoro AK, Mwangi J, Juma F, Mugoya IK, Scott JA. Changing 
use of surgical antibiotic prophylaxis in Thika Hospital, Kenya: a quality 
improvement intervention with an interrupted time series design. PLoS One. 
2013;8(11):e78942. 
10. Bull AL, Worth LJ, Spelman T, Richards MJ. Antibiotic Prescribing Practices 
for Prevention of Surgical Site Infections in Australia: Increased Uptake of National 
Guidelines after Surveillance and Reporting and Impact on Infection Rates. Surg 
Infect (Larchmt). 2017;18(7):834-40. 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
7 
 
11. Kilan R, Moran D, Eid I, Okeahialam C, Quinn C, Binsaddiq W, et al. 
Improving antibiotic prophylaxis in gastrointestinal surgery patients: A quality 
improvement project. Ann Med Surg (Lond). 2017;20:6-12. 
12. Berrios-Torres SI, Umscheid CA, Bratzler DW, Leas B, Stone EC, Kelz RR, 
et al. Centers for Disease Control and Prevention Guideline for the Prevention of 
Surgical Site Infection, 2017. JAMA Surg. 2017;152(8):784-91. 
13. Skoog G, Struwe J, Cars O, Hanberger H, Odenholt I, Prag M, et al. Repeated 
nationwide point-prevalence surveys of antimicrobial use in Swedish hospitals: data 
for actions 2003-2010. Euro Surveill. 2016;21(25). 
14. Touboul-Lundgren P, Jensen S, Drai J, Lindbaek M. Identification of cultural 
determinants of antibiotic use cited in primary care in Europe: a mixed research 
synthesis study of integrated design "Culture is all around us". BMC Public Health. 
2015;15(1):908. 
15. Broom A, Broom J, Kirby E. Cultures of resistance? A Bourdieusian analysis 
of doctors' antibiotic prescribing. Soc Sci Med. 2014;110:81-8. 
16. Broom J, Broom A, Adams K, Plage S. What prevents the intravenous to oral 
antibiotic switch? A qualitative study of hospital doctors' accounts of what influences 
their clinical practice. J Antimicrob Chemother. 2016;71(8):2295-9. 
17. Charani E, Castro-Sanchez E, Sevdalis N, Kyratsis Y, Drumright L, Shah N, et 
al. Understanding the determinants of antimicrobial prescribing within hospitals: the 
role of "prescribing etiquette". Clin Infect Dis. 2013;57(2):188-96. 
18. Riley RG, Manias E. Governance in operating room nursing: nurses' 
knowledge of individual surgeons. Soc Sci Med. 2006;62(6):1541-51. 
19. Finn R, Learmonth M, Reedy P. Some unintended effects of teamwork in 
healthcare. Soc Sci Med. 2010;70(8):1148-54. 
20. Whyte S, Cartmill C, Gardezi F, Reznick R, Orser BA, Doran D, et al. Uptake 
of a team briefing in the operating theatre: a Burkean dramatistic analysis. Soc Sci 
Med. 2009;69(12):1757-66. 
21. Broom JK, Broom AF, Kirby ER, Post JJ. How do professional relationships 
influence surgical antibiotic prophylaxis decision making? A qualitative study. Am J 
Infect Control. 2017. 
22. Villafranca A, Hamlin C, Enns S, Jacobsohn E. Disruptive behaviour in the 
perioperative setting: a contemporary review. Can J Anaesth. 2017;64(2):128-40. 
23. Jayasuriya-Illesinghe V, Guruge S, Gamage B, Espin S. Interprofessional 
work in operating rooms: a qualitative study from Sri Lanka. BMC Surg. 
2016;16(1):61. 
24. Giusti A, Spila Alegiani S, Ciofi Degli Atti ML, Colaceci S, Raschetti R, 
Arace P, et al. Surgical antibiotic prophylaxis in children: a mixed method study on 
healthcare professionals attitudes. BMC Pediatr. 2016;16(1):203. 
25. Charani E, Tarrant C, Moorthy K, Sevdalis N, Brennan L, Holmes AH. 
Understanding antibiotic decision making in surgery-a qualitative analysis. Clin 
Microbiol Infect. 2017;23(10):752-60. 
26. Broom J, Broom A, Plage S, Adams K, Post JJ. Barriers to uptake of 
antimicrobial advice in a UK hospital: a qualitative study. J Hosp Infect. 
2016;93(4):418-22. 
27. Broom JK, Broom AF, Kirby ER, Gibson AF, Post JJ. Clinical and social 
barriers to antimicrobial stewardship in pulmonary medicine: A qualitative study. Am 
J Infect Control. 2017. 
28. Bjornsdottir I, Hansen EH. Ethical dilemmas in antibiotic prescribing: analysis 
of everyday practice. J Clin Pharm Ther. 2002;27(6):431-40. 
M
AN
US
CR
IP
T
 
AC
CE
PT
ED
ACCEPTED MANUSCRIPT
8 
 
29. Glotzbecker MP, Riedel MD, Vitale MG, Matsumoto H, Roye DP, Erickson 
M, et al. What's the evidence? Systematic literature review of risk factors and 
preventive strategies for surgical site infection following pediatric spine surgery. J 
Pediatr Orthop. 2013;33(5):479-87. 
30. Broom A, Kirby E, Gibson AF, Post JJ, Broom J. Myth, Manners, and 
Medical Ritual: Defensive Medicine and the Fetish of Antibiotics. Qual Health Res. 
2017;27(13):1994-2005. 
31. Bruny J, Ziegler M. Surgical innovation-enhanced quality and the processes 
that assure patient/provider safety: A surgical conundrum. Semin Pediatr Surg. 
2015;24(6):323-6. 
 
